glp 1 and glp 2 drugs How GLP-1 medications are transforming diabetes weight loss treatment TrimRX | GLP-1 vs GIP:

Though there has been some preliminary data that GLP-1RAs might protect against cognitive decline and dementia, the research is still in clinical trials

Expanding insurance coverage, rising obesity prevalence and broader physician adoption are all contributing to the rapid mainstream acceptance of these therapies

Through a personalized titration plan, theyll monitor how your body responds and make thoughtful adjustments to your dose, so you can progress at your own pace without compromising safety

January 22, 2026: Gastroparesis Lawsuits Progressing While a lot of attention in recent months has been devoted to the emerging vision loss litigation, gastroparesis lawsuits involving Ozempic and other GLP-1s are still progressing

Therefore, growing interest and evidence support both stimulation and inhibition of GIP receptor signaling

(n.d.-b).